Innovative Management of Recurrent Furunculosis
May 2010
in “
Dermatologic Clinics
”
TLDR Recurrent furunculosis can be managed with antibiotics, decolonization, and decontamination, with potential future use of vaccines and bacteriophage therapy.
The document discussed the management of recurrent furunculosis, primarily caused by Staphylococcus aureus, with a focus on CA-MRSA infections. The standard treatment involved incision and drainage, but recurrent cases required a combination of antibiotics, decolonization, and decontamination. Empiric treatment with TMP/SMX or doxycycline was recommended, with vancomycin for hospitalized patients. The document also highlighted the potential of vaccines and bacteriophage therapy as innovative approaches, although these were still in development stages.
